Current position:Home >Product >
[4-[4-[C-(4-bromophenyl)-N-ethoxy-carbonimidoyl]-1-piperidyl]-4-methyl-1-piperidyl]-(2,4-dimethyl-1-oxido-pyridin-3-yl)methanone
[4-[4-[C-(4-bromophenyl)-N-ethoxy-carbonimidoyl]-1-piperidyl]-4-methyl-1-piperidyl]-(2,4-dimethyl-1-oxido-pyridin-3-yl)methanone(370893-06-4)
- Name: [4-[4-[C-(4-bromophenyl)-N-ethoxy-carbonimidoyl]-1-piperidyl]-4-methyl-1-piperidyl]-(2,4-dimethyl-1-oxido-pyridin-3-yl)methanone
- Synonyms:[1,4'-Bipiperidine]-4-methanimine,a-(4-bromophenyl)-1'-[(2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-N-ethoxy-4'-methyl-,(aZ)- (9CI);4-[(Z)-(4-Bromophenyl)(ethoxyimino)methyl]-1'-[(2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'-methyl-1,4'-bipiperidine;Ancriviroc; SC 351125; SCH-C; Sch 351125; Schering C
- Molecular Formula:C28H37 Br N4 O3
- Molecular Weight:557.531
- CAS Registry Number:370893-06-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.370893-06-4 {4-[(Z)-(4-Bromophenyl)(ethoxyimino)methyl]-4'-methyl-1,4'-bipipe ridin-1'-yl}(2,4-dimethyl-1-oxido-3-pyridinyl)methanone
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.370893-06-4 Ancriviroc
Assay:鈮?8% Appearance:Solid powder Package:inquiry Storage:Store at -20 掳C Transportation:inquiry Application:Ancriviroc, an oximino-piperidino-piperidine-amide, is a CCR5 receptor antagonist.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 142653-61-0/Propanenitrile,3-[(3Z)-3-hexenyloxy]-
- 22288-77-3/2,5-diaminothiazolo(4,5-d)pyrimidin-7-(6H)-one
- 100310-83-6/1,6-Heptanediamine,N1,N6-bis[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-3,3,6-trimethyl-
- 74401-28-8/methyl(methyl-9,10-ethano-9(10H)-anthryl)ammonium methanesulphonate
- 5290-29-9/TRIETHYLACETOXYSILANE
- 1817-47-6/1-ISOPROPYL-4-NITROBENZENE
- 184582-66-9/2,7-Dihydroxy-9-(3-aminopropyl)thioacridine
- 75088-36-7/Butanoic acid,3-methyl-,4-[(acetyloxy)- methyl]-1,4a,5,6,7,7a-hexahydro-7-hydroxy- 7-(iodomethyl)cyclopenta[c]pyran-1,6-diyl ester,(1S,4aS,6S,7S,7aS)-
- 112-28-7/3-(3-methoxypropoxy)propanol
- 172282-24-5/6H-Dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one,11-ethyl-5,11-dihydro-2-(1H-indol-3-yl)-5-methyl-
- 154277-76-6/5H-Dibenzo[b,h]fluorene-5,11,13-trione,1,4,6,7,10-pentahydroxy-3-[(1R)-1-hydroxy-4-methyl-3-penten-1-yl]-12-(3-methyl-2-buten-1-yl)-
- 35470-61-2/(3alpha)-3-hydroxybeyer-15-ene-2,12-dione
- 6360-54-9/C.I. DIRECT BROWN 154, DISODIUM SALT (8CI)
- 57281-79-5/1385-04-2
- 69011-80-9/Ethanaminium, 2-(((4,6-bis((methoxymethyl)amino)-1,3,5-triazin-2-yl)(methoxymethyl)amino)methoxy)-N-ethyl-N,N-bis(2-hydroxyethyl)-, N,N-bis((C16-18-alkyloxy)methyl) derivs, Et sulfates (salts)
- 54717-80-5/(1R,2R,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl 3-oxobutanoate
- 16785-26-5/3-[4-(2-methylphenyl)piperazin-1-yl]-1-(3,4,5-trimethoxyphenyl)propan-1-one hydrochloride (1:1)
- 370893-06-4/[4-[4-[C-(4-bromophenyl)-N-ethoxy-carbonimidoyl]-1-piperidyl]-4-methyl-1-piperidyl]-(2,4-dimethyl-1-oxido-pyridin-3-yl)methanone
- 62298-52-6/3-Methoxy-18-methyl-8,14-seco-1,3,5(10),9(11)-estrateraene-14,17-dione
- 101921-36-2/Azuleno[4,5-b]furan-2,7-dione,9-[(b-D-glucopyranosyloxy)methyl]-3,3a,4,5,9a,9b-hexahydro-6-methyl-3-methylene-,(3aS,9aS,9bS)-
- 505-71-5/N,N'-dinitroethylenediamine
- 3090-36-6/tributyl(lauroyloxy)stannane
- 86746-08-9/N-{3-[4-(2-methylphenyl)piperazin-1-yl]propyl}-2-(2,4,6-trimethylphenoxy)acetamide dihydrochloride
- 36162-13-7/5-fluoro-1-[2-(furan-2-yl)-2-oxoethyl]pyrimidine-2,4(1H,3H)-dione
- 140631-27-2/12-Hydroxyjasmonic acid
- 85303-87-3/3-(2-Ethylphenyl)-5-piperonyl-1H-1,2,4-triazole
- 68901-19-9/2-(aminothioxomethyl)dithiocarbazic acid, compound with triethylamine (1:1)
- 83245-20-9/Grotan HD-II
- 64731-99-3/methyl (carbamoylamino)(methylsulfanyl)acetate
- 19293-83-5/1-[2-(5-carbamoylpyridin-1-yl)ethyl]pyridine-5-carboxamide dibromide